Maximus (NYSE:MMS) Raised to “Outperform” at Raymond James

Maximus (NYSE:MMS) was upgraded by equities research analysts at Raymond James from a “market perform” rating to an “outperform” rating in a research report issued to clients and investors on Thursday, MarketBeat.com reports. The brokerage currently has a $90.00 price target on the health services provider’s stock. Raymond James’ price objective indicates a potential upside of 16.13% from the company’s previous close.

Separately, StockNews.com cut Maximus from a “buy” rating to a “hold” rating in a report on Friday, December 27th.

Maximus Stock Up 2.2 %

NYSE MMS opened at $77.50 on Thursday. The company has a market capitalization of $4.67 billion, a P/E ratio of 15.50 and a beta of 0.73. Maximus has a 12 month low of $69.72 and a 12 month high of $93.97. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.49 and a quick ratio of 1.49. The company’s 50 day simple moving average is $77.76 and its 200 day simple moving average is $85.27.

Insider Activity at Maximus

In other Maximus news, CEO Bruce Caswell bought 3,500 shares of the company’s stock in a transaction dated Tuesday, December 17th. The shares were bought at an average price of $70.64 per share, for a total transaction of $247,240.00. Following the acquisition, the chief executive officer now directly owns 275,929 shares of the company’s stock, valued at approximately $19,491,624.56. This trade represents a 1.28 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Michelle F. Link sold 2,208 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $73.83, for a total transaction of $163,016.64. Following the transaction, the insider now directly owns 6,567 shares in the company, valued at $484,841.61. The trade was a 25.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders bought 7,063 shares of company stock worth $502,017. 1.40% of the stock is owned by corporate insiders.

Institutional Trading of Maximus

A number of institutional investors have recently bought and sold shares of the company. Inspire Advisors LLC increased its holdings in shares of Maximus by 1.4% during the 2nd quarter. Inspire Advisors LLC now owns 8,768 shares of the health services provider’s stock valued at $751,000 after acquiring an additional 121 shares during the last quarter. Petrus Trust Company LTA grew its holdings in Maximus by 2.7% in the 3rd quarter. Petrus Trust Company LTA now owns 7,084 shares of the health services provider’s stock valued at $660,000 after buying an additional 185 shares during the last quarter. Holocene Advisors LP increased its position in Maximus by 6.5% in the 3rd quarter. Holocene Advisors LP now owns 3,927 shares of the health services provider’s stock worth $366,000 after buying an additional 239 shares during the period. New Century Financial Group LLC grew its stake in shares of Maximus by 2.1% in the second quarter. New Century Financial Group LLC now owns 13,003 shares of the health services provider’s stock worth $1,114,000 after acquiring an additional 264 shares during the last quarter. Finally, V Square Quantitative Management LLC bought a new position in shares of Maximus during the 3rd quarter worth about $25,000. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.